14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $65.50 $83.89 Tuesday, 23rd Apr 2024 AXSM stock ended at $73.08. This is 2.78% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 5.73% from a day low at $70.30 to a day high of $74.33.
90 days $65.50 $98.40
52 weeks $55.03 $98.40

Historical Axsome Therapeutics prices

Date Open High Low Close Volume
Jun 04, 2021 $61.82 $62.50 $60.10 $61.32 208 300
Jun 03, 2021 $60.34 $62.16 $59.82 $61.70 221 582
Jun 02, 2021 $61.81 $62.63 $59.83 $60.56 339 027
Jun 01, 2021 $61.35 $62.45 $60.01 $61.70 418 745
May 28, 2021 $61.28 $61.80 $60.00 $60.71 296 014
May 27, 2021 $56.39 $61.17 $55.77 $60.50 638 904
May 26, 2021 $55.45 $56.77 $55.16 $56.23 258 275
May 25, 2021 $54.85 $56.24 $54.36 $54.68 346 422
May 24, 2021 $56.11 $56.40 $55.01 $55.03 419 699
May 21, 2021 $56.08 $57.00 $55.12 $55.37 217 255
May 20, 2021 $55.66 $56.40 $54.55 $55.55 288 997
May 19, 2021 $57.51 $58.00 $55.19 $55.55 325 850
May 18, 2021 $59.28 $60.37 $57.59 $58.04 362 022
May 17, 2021 $58.70 $59.39 $57.86 $58.96 220 648
May 14, 2021 $60.80 $61.19 $57.82 $58.42 332 663
May 13, 2021 $57.79 $60.24 $57.25 $60.03 398 969
May 12, 2021 $56.16 $58.22 $55.55 $57.01 293 849
May 11, 2021 $52.72 $57.66 $52.11 $57.03 342 292
May 10, 2021 $55.36 $56.78 $53.78 $54.39 349 399
May 07, 2021 $56.44 $57.99 $56.00 $56.96 308 024
May 06, 2021 $58.45 $58.45 $55.00 $56.36 477 702
May 05, 2021 $58.77 $59.65 $57.47 $58.15 340 249
May 04, 2021 $60.86 $60.98 $57.78 $58.08 571 560
May 03, 2021 $61.54 $62.41 $60.71 $61.55 319 431
Apr 30, 2021 $61.18 $63.00 $59.52 $60.46 411 137
Click to get the best stock tips daily for free!

About Axsome Therapeutics

Axsome Therapeutics Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinical trial to treat Alzheimer's disease agitation, as well as that has completed phase II clinical trial ... AXSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT